FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 278 of 278

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
TTNP Nasdaq Titan Pharmaceuticals, Inc. 2830
TYRA Nasdaq Tyra Biosciences, Inc. 2830
UBX Nasdaq Unity Biotechnology, Inc. 2830
UCBJY Over the counter UCB SA 2830
UG Nasdaq United-Guardian, Inc. 2830
UPC Nasdaq Universe Pharmaceuticals INC 2830
UPXI Nasdaq Upexi, Inc. 2830
VALN Nasdaq Valneva SE 2830
VCYT Nasdaq Veracyte, Inc. 2830
VERU Nasdaq Veru Inc. 2830
VIGL Nasdaq Vigil Neuroscience, Inc. 2830
VOR Nasdaq Vor Biopharma Inc. 2830
VRDN Nasdaq Viridian Therapeutics, Inc. 2830
VRNA Nasdaq Verona Pharma plc 2830
VXRT Nasdaq Vaxart, Inc. 2830
VYNE Nasdaq VYNE Therapeutics Inc. 2830
WALD Nasdaq Waldencast plc 2830
WVE Nasdaq Wave Life Sciences Ltd. 2830
XBIT Nasdaq XBiotech Inc. 2830
XCUR Nasdaq Exicure, Inc. 2830
XENE Nasdaq Xenon Pharmaceuticals Inc. 2830
XFOR Nasdaq X4 Pharmaceuticals, Inc. 2830
XTLB Nasdaq XTL Biopharmaceuticals Ltd. 2830
ZLAB Nasdaq Zai Lab Limited 2830
ZLDPY Over the counter Zealand Pharma A/S 2830
ZTS New York Zoetis Inc. 2830
ZVRA Nasdaq Zevra Therapeutics, Inc. 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 278 of 278